Attending the New York Venture Summit Nov 18–19 · Javits Center

DeNext AI

Early signal Life sciences deal flow

See what's emerging before everyone else.

By the time a company is in your database, every other fund has seen it too. DeNext AI shows you who is emerging before the round, with the credibility signals to back each one: proprietary, event-based data on life sciences companies, searchable by target and modality, scored and ranked.

Join the waitlist See the dataset
HOW A COMPANY BECOMES VISIBLE ILLUSTRATIVE ORDER · TIMING VARIES
DENEXT AI SEES IT HERE First signal A company, target or modality surfaces for the first time.
PUBLIC RECORD Paper or patent
PUBLIC RECORD Press release
PUBLIC RECORD Funding round Where most databases pick it up.
REAL EXAMPLE Orchestra Bio
MARCH 2026 In the DeNext AI dataset
20 OCTOBER 2026 Acquired by OpenAI
7 months between the two
FIRST APPEARANCENEW PARTNERSHIPOWNERSHIP CHANGENEW TARGETMODALITY MOMENTUMFOUNDER MOVEPIPELINE SHIFT

A company you didn't know, and a reason to call it now.

Every company is one clean record: what it is building, when it first surfaced, how credible it looks, and how it scores. Everything below is sample data showing the format.

SIGNAL CARD SAMPLE DATA

Company name masked

Seed-stage · Boston, MA · Bispecific ADC platform for solid tumours

MODALITY · ADC TARGET · B7-H3 INDICATION · SCLC
FIRST SEEN Mar 2025
PUBLIC RECORD ON THAT DATE No disclosed round. No database profile.
SIGNALS SINCE
Mar 2025 First appearance HIGH
Sep 2025 Co-presents with a top-20 pharma HIGH
Mar 2026 Discloses a second target MED
CREDIBILITY SIGNALS
Same story two years running, with new data each time
Invited talk, shared with a top-20 pharma
Ownership verified: independent, no parent company
No clinical data shown yet
SIGNAL SCORE 87
Earliness
Traction
Credibility
Thesis fit
SOURCING LIST · TRY IT SAMPLE DATA

Ranked against your thesis

#COMPANYMODALITYFIRST SEENSCORE
LANDSCAPE SAMPLE DATA

Which modalities are filling up

Companies, 2025 Companies, 2026
In vivo CAR-T 619
Radioligand 917
ADC 2126
siRNA 1213
TRACK RECORD SAMPLE FORMAT

Every call dated. Every outcome logged.

COMPANY SCORED SCORE OUTCOME
Company name masked Jul 2026 87 OPEN
Company name masked Jul 2026 81 OPEN
Company name masked Jul 2026 74 OPEN
Company name masked Jul 2026 68 OPEN

Every call is logged with its date and stays open until it resolves. You see the misses as well as the hits.

Keep your databases. Add what they can't see.

THE DATABASES YOU HAVE

Public data

  • Funding rounds, filings and press releases
  • Records a deal once it has been announced
  • The same facts for every fund that subscribes
DENEXT AI

Proprietary, event-based data

  • Companies, targets and modalities as they first surface
  • Signals from before the round or the deal
  • Collected and structured by us, not licensed from a public feed

Nothing to rip out and nothing to migrate. DeNext AI sits alongside your stack and covers the stretch before the public record exists.

It lands where you already work.

No new tool for the team to learn. The data arrives in the systems your deal flow already runs through.

API

Pull it into your own systems

Query companies, targets, modalities and scores from your warehouse or internal tools.

CRM

Signals on the records you already keep

New signals and scores pushed onto the company records in your CRM, so nobody has to check a second tool.

MCP

Ask your AI assistant

Connect the dataset to the assistant your team already uses and ask in plain language, with sources.

CSV

Export any list

Download a ranked list or a landscape for your own models and memos.

DASHBOARD

Search in the browser

Filter by target, modality, stage and first-seen date with nothing to install.

Four jobs, one dataset

01

Deal sourcing

Be the first call, not the fifth. Find companies and founders while they are still off the usual lists.

02

Due diligence

Check the story before you fund it. Has it stayed consistent, has the data improved, and who has put their name beside it?

03

Trend forecasting

Know which modalities, targets and diseases are scaling next, before the money moves.

04

Portfolio monitoring

See the competitors coming for your portfolio companies while there is still time to act.

Good enough to cite in an investment memo.

An early signal you have to fact-check saves you nothing. A statement that can't be traced to a source doesn't ship.

HIGH · MED · LOW

Confidence on every field

You see how sure the data is before a claim reaches your memo.

M&A FLAG

Ownership checked, not assumed

Acquisitions and subsidiaries are flagged, and name variations resolve to one company.

SCORE

Scores you can open up

Every ranking shows the signals behind it, so you can argue with the reasoning.

For the people whose job is seeing it first.

Early-stage biotech VC

Private companies and scientific founders, surfaced before they raise.

Crossover funds

Competitive landscapes by modality and target, and private companies approaching the public markets.

Corporate VC and BD

One dataset for the venture team and for the parent company's scouting.

Be first to see the early signals.

The deal you see late is the deal you pay more for. Access is opening in stages: join the waitlist and we'll be in touch when a place opens for your firm.